Biospherix
In 2014, BioSpherix Medical was established to accommodate the demand for a vast array of equipment for cell research and cell/gene therapies. The self-contained Xvivo GMP System is the first and only cytocentric platform for producing GMP compliant, clinical grade cell and gene therapies without the need to build and operate costly cleanroom facilities.
